Dgs Capital Management, LLC Eagle Pharmaceuticals, Inc. Transaction History
Dgs Capital Management, LLC
- $344 Million
- Q1 2024
A detailed history of Dgs Capital Management, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Dgs Capital Management, LLC holds 61,944 shares of EGRX stock, worth $265,120. This represents 0.09% of its overall portfolio holdings.
Number of Shares
61,944
Previous 11,419
442.46%
Holding current value
$265,120
Previous $59,000
449.15%
% of portfolio
0.09%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
79Shares Held
9.89MCall Options Held
1.01MPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT1.96MShares$8.4 Million0.73% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.21MShares$5.19 Million2.46% of portfolio
-
Citigroup Inc1MShares$4.29 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT697KShares$2.98 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA564KShares$2.42 Million0.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $55.7M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...